Literature DB >> 30853465

The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Jennifer L Whitwell1, Peter Martin2, Jonathan Graff-Radford3, Mary M Machulda4, Matthew L Senjem5, Christopher G Schwarz6, Stephen D Weigand2, Anthony J Spychalla6, Daniel A Drubach3, Clifford R Jack6, Val J Lowe6, Keith A Josephs3.   

Abstract

INTRODUCTION: Little is known about the role of age on neurodegeneration and protein deposition in atypical variants of Alzheimer's disease (AD).
METHODS: Regional tau and β-amyloid positron emission tomography standard uptake value ratios and gray matter volumes were calculated in a cohort of 42 participants with atypical AD. The relationship between regional metrics and age was modeled using a Bayesian hierarchical linear model.
RESULTS: Age was strongly associated with tau uptake across all cortical regions, particularly parietal, with greater uptake in younger participants. Younger age was associated with smaller parietal and lateral temporal volumes. Regional β-amyloid differed little by age. Age showed a stronger association with tau than volume and β-amyloid in all cortical regions. Age was not associated with cognitive performance. DISCUSSION: Age is an important determinant of severity of cortical tau uptake in atypical AD, with young participants more likely to show widespread and severe cortical tau uptake.
Copyright © 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AV-1451; Amyloid; Magnetic resonance imaging; Pittsburgh compound B; Positron emission tomography; age; tau

Mesh:

Substances:

Year:  2019        PMID: 30853465      PMCID: PMC6511453          DOI: 10.1016/j.jalz.2018.12.016

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  41 in total

1.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

2.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

3.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

4.  Visual association pathology in preclinical Alzheimer disease.

Authors:  Ann C McKee; Rhoda Au; Howard J Cabral; Neil W Kowall; Sudha Seshadri; Caroline A Kubilus; Jon Drake; Philip A Wolf
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

5.  Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women.

Authors:  Limor Raz; M Jayachandran; Nirubol Tosakulwong; Timothy G Lesnick; Samantha M Wille; Matthew C Murphy; Matthew L Senjem; Jeffrey L Gunter; Prashanthi Vemuri; Clifford R Jack; Virginia M Miller; Kejal Kantarci
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

6.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

7.  FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.

Authors:  Ajay Madhavan; Jennifer L Whitwell; Stephen D Weigand; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Matthew L Senjem; Jeffrey L Gunter; Val J Lowe; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome.

Authors:  Bradford C Dickerson; Michael Brickhouse; Scott McGinnis; David A Wolk
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-22

9.  Patterns of progressive atrophy vary with age in Alzheimer's disease patients.

Authors:  Cassidy M Fiford; Gerard R Ridgway; David M Cash; Marc Modat; Jennifer Nicholas; Emily N Manning; Ian B Malone; Geert Jan Biessels; Sebastien Ourselin; Owen T Carmichael; M Jorge Cardoso; Josephine Barnes
Journal:  Neurobiol Aging       Date:  2017-11-14       Impact factor: 4.673

10.  Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.

Authors:  Keith A Josephs; Dennis W Dickson; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Leonard Petrucelli; Amanda M Liesinger; Matthew L Senjem; Anthony J Spychalla; David S Knopman; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell
Journal:  Lancet Neurol       Date:  2017-09-11       Impact factor: 44.182

View more
  16 in total

1.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

3.  Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.

Authors:  Adam Martersteck; Jaiashre Sridhar; Christina Coventry; Sandra Weintraub; M-Marsel Mesulam; Emily Rogalski
Journal:  Alzheimers Dement       Date:  2021-09-08       Impact factor: 21.566

4.  Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.

Authors:  Neha Atulkumar Singh; Jonathan Graff-Radford; Mary M Machulda; Christopher G Schwarz; Matthew C Baker; Rosa Rademakers; Nilufer Ertekin-Taner; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

5.  Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Jonathan Graff-Radford; Nilufer Ertekin-Taner; Mary M Machulda; Joseph R Duffy; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2021-08-25       Impact factor: 5.133

6.  Four distinct trajectories of tau deposition identified in Alzheimer's disease.

Authors:  Jacob W Vogel; Alexandra L Young; Neil P Oxtoby; Ruben Smith; Rik Ossenkoppele; Olof T Strandberg; Renaud La Joie; Leon M Aksman; Michel J Grothe; Yasser Iturria-Medina; Michael J Pontecorvo; Michael D Devous; Gil D Rabinovici; Daniel C Alexander; Chul Hyoung Lyoo; Alan C Evans; Oskar Hansson
Journal:  Nat Med       Date:  2021-04-29       Impact factor: 53.440

7.  Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Orit H Lesman-Segev; Suzanne L Baker; Lauren Edwards; Leonardo Iaccarino; David N Soleimani-Meigooni; Taylor Mellinger; Mustafa Janabi; Zachary A Miller; David C Perry; Julie Pham; Amelia Strom; Maria Luisa Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Neurology       Date:  2020-12-01       Impact factor: 9.910

8.  Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.

Authors:  Kennedy A Josephs; Nha Trang Thu Pham; Jonathan Graff-Radford; Mary M Machulda; Val J Lowe; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

9.  Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.

Authors:  Irene Sintini; Jonathan Graff-Radford; David T Jones; Hugo Botha; Peter R Martin; Mary M Machulda; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Cereb Cortex       Date:  2021-02-05       Impact factor: 5.357

10.  Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum.

Authors:  Leonardo Iaccarino; Renaud La Joie; Lauren Edwards; Amelia Strom; Daniel R Schonhaut; Rik Ossenkoppele; Julie Pham; Taylor Mellinger; Mustafa Janabi; Suzanne L Baker; David Soleimani-Meigooni; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Cereb Cortex       Date:  2021-01-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.